查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067540

糖尿病醫療設備市場規模、佔有率和趨勢分析報告：按類型、分銷管道、最終用途、地區和細分市場預測（2026-2033 年）

Diabetes Devices Market Size, Share & Trends Analysis Report By Type, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

糖尿病醫療設備市場概述

2025年全球糖尿病醫療設備市場規模估計為458.5億美元，預計2033年將達到1,016.6億美元。

預計從 2026 年到 2033 年，該市場將以 10.5% 的複合年成長率成長。推動該市場成長的主要因素包括糖尿病患者人數的增加、技術進步、胰島素輸送裝置的日益普及以及肥胖率的上升。

主要製造商正致力於技術創新和先進產品的研發，以確保在糖尿病護理設備市場中佔據顯著的市場佔有率。例如，2025年1月，德康醫療宣布透過與其數位健康和​​自動胰島素輸注平台的新整合，擴展其人工智慧驅動的連續血糖監測（CGM）生態系統。此舉旨在提升個人化糖尿病管理和遠端患者監護能力。預計此舉將增強該公司互聯糖尿病護理產品組合，加速先進CGM和自動胰島素輸注技術在全球範圍內的應用，並最終促進糖尿病護理設備市場的成長。

全球糖尿病盛行率的不斷上升，使得預測期內對糖尿病照護設備的需求強勁。根據國際糖尿病聯盟（IDF）將於2025年發布的第11版《糖尿病地圖集》，目前全球約有5.89億20至79歲的成年人患有糖尿病，約佔全球成年人口的九分之一。 IDF進一步預測，到2050年，糖尿病患者人數將增加至約8.53億，反映出全球疾病負擔的迅速加重。此外，超過40%的糖尿病患者尚未確診，這增加了嚴重併發症的風險，並推動了對持續血糖監測系統、胰島素輸注設備和早期診斷技術的需求。此外，超過81%的糖尿病患者居住在中低收入國家，這凸顯了新興市場中經濟實惠、互聯互通的糖尿病護理解決方案的巨大成長潛力。預計在預測期內，糖尿病盛行率的上升、肥胖率的上升、久坐的生活方式以及人口老化等因素將顯著推動糖尿病醫療設備市場的成長。

糖尿病照護藥物和醫療設備市場需求的成長主要源自於人們日益成長的需求，即減輕糖尿病相關併發症、預防長期住院、降低糖尿病患者的死亡率。糖尿病醫療設備，例如持續血糖監測儀、胰島素輸注系統和血糖值儀，能夠即時追蹤和有效管理血糖值，幫助患者及時採取措施控制病情。這些技術有助於提高治療依從性，並使醫護人員能夠快速調整治療方案，從而改善疾病管理和患者預後。此外，先進糖尿病照護解決方案的日益普及降低了嚴重健康併發症的風險，並提高了糖尿病患者的整體生活品質。因此，這些醫療設備的廣泛應用透過改善患者照護、提高臨床效率和支援長期疾病管理，持續推動糖尿病照護藥品和醫療設備市場的成長。

該市場的成長主要受糖尿病盛行率上升的驅動，而糖尿病盛行率上升則源自於人口老化、肥胖和不健康的生活方式。肥胖是導致糖尿病的主要因素之一。根據世界衛生組織（WHO）2025年發布的最新數據，2022年，全球18歲以上成年人中，超過25億人超重，其中超過8.9億人肥胖。此外，自1990年以來，全球肥胖盛行率已加倍以上，目前約有16%的成年人被歸類為肥胖。世界肥胖聯盟在《2025年世界肥胖地圖集》中指出，到2035年，肥胖成年人的數量將增加近15.3億。不斷上升的肥胖率顯著增加了第二型糖尿病、心血管疾病和代謝性疾病的風險，這將推動預測期內對持續血糖監測系統、胰島素輸注裝置和其他先進糖尿病管理技術的需求。

龐大的老齡人口、價格合理的醫療保健服務、成本效益高的勞動力以及相對寬鬆的法規環境，正在推動糖尿病醫療設備製造商的業務擴張。各公司優先考慮在新興市場取得商機，以增強其市場主導地位。先進胰島素幫浦和胰島素筆等技術的進步也推動了對糖尿病醫療設備的需求。領先企業正專注於技術創新和開發先進產品，以確保獲得可觀的市場佔有率。例如，Medtronic於2025年4月宣布，已向美國FDA提交了MiniMed 780G的申請。 MiniMed 780G是一款可與雅培先進的CGM平台整合的互通胰島素幫浦。預計這項進展將提高互通性，增強血糖控制的自動化程度，並擴大全球市場對先進胰島素輸注技術的取得途徑，從而加速互聯糖尿病管理生態系統的發展。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：糖尿病醫療設備市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 糖尿病醫療設備市場分析工具

第4章：糖尿病醫療設備市場：按類型分類的估算與趨勢分析

  • 糖尿病醫療設備市場：按類型分類的波動分析
  • 糖尿病醫療設備市場：按類型分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 背景音樂設備
    • 自測量設備
    • 連續血糖監測設備
  • 胰島素輸注裝置
    • 筆式胰島素注射器
    • 泵浦
    • 注射器
    • 噴射注射器

第5章：糖尿病醫療設備市場：按分銷管道分類的估算與趨勢分析

  • 糖尿病醫療設備市場：按分銷管道分類的波動分析
  • 糖尿病醫療設備市場：按分銷管道分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 醫院藥房
  • 零售藥房
  • 糖尿病診所/中心
  • 網路藥房
  • 其他

第6章：糖尿病醫療設備市場：依最終用途分類的估算與趨勢分析

  • 糖尿病醫療設備市場：依最終用途分類的波動分析
  • 糖尿病醫療設備市場：依最終用途分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 醫院
  • 診斷中心
  • 居家照護

第7章：糖尿病醫療設備市場：區域估算與趨勢分析

  • 區域儀錶板
  • 糖尿病醫療設備市場波動區域分析
  • 糖尿病醫療設備市場：區域估算與趨勢分析
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 參與企業的分類
  • 主要公司簡介
    • Medtronic plc
    • Abbott Laboratories
    • F.Hoffmann-La-Ltd.
    • Bayer AG
    • Lifescan, Inc.
    • B Braun Melsungen AG
    • Lifescan, Inc.
    • Dexcom Inc.
    • Insulet Corporation
    • Ypsomed Holdings
    • Companion Medical
    • Sanofi
    • Valeritas Holding Inc.
    • Novo Nordisk
    • Arkray, Inc.
Product Code: 978-1-68038-873-2

Diabetes Devices Market Summary

The global diabetes devices market sizewas estimated at USD 45.85 billion in 2025 and is projected to reach USD 101.66 billion by 2033, growing at a CAGR of 10.5% from 2026 to 2033. The market is primarily driven by growing prevalence of diabetes, advanced technology, the growing usage of insulin delivery devices, and the rise in obesity rates.

Major manufacturers are concentrating on technological innovation and the creation of advanced products to secure a significant portion of the diabetes care devices market. For instance, in January 2025, Dexcom announced the expansion of its AI-enabled continuous glucose monitoring ecosystem through new integrations with digital health and automated insulin delivery platforms to improve personalized diabetes management and remote patient monitoring capabilities. The development strengthened the company's connected diabetes care portfolio and is expected to accelerate the adoption of advanced CGM and automated insulin delivery technologies globally, thereby supporting the diabetes management devices market growth.

The increasing prevalence of diabetes worldwide has created a strong demand for diabetes devices over the forecast period. According to the latest 11th Edition of the International Diabetes Federation (IDF) Diabetes Atlas published in 2025, approximately 589 million adults aged 20-79 years are currently living with diabetes globally, representing nearly 1 in 9 adults worldwide. The organization further projects that the number of adults living with diabetes likely to increase to nearly 853 million by 2050, reflecting the rapidly growing global disease burden. In addition, more than 40% of diabetic individuals remain undiagnosed, increasing the risk of severe complications and driving the need for continuous glucose monitoring systems, insulin delivery devices, and early diagnostic technologies. Furthermore, over 81% of people with diabetes live in low- and middle-income countries, highlighting significant growth opportunities for affordable and connected diabetes care solutions across emerging markets. These rising prevalence trends, coupled with increasing obesity rates, sedentary lifestyles, and aging populations, are expected to significantly support the growth of the diabetes devices market during the forecast period.

The increasing demand in the diabetes care drugs devices market is largely driven by the growing need to reduce diabetes-related complications, prevent prolonged hospital stays, and lower mortality rates among diabetic patients. Diabetes devices such as continuous glucose monitors, insulin delivery systems, and blood glucose monitoring devices enable real-time tracking and effective management of blood sugar levels, helping patients take timely action to control their condition. These technologies support better treatment adherence and allow healthcare providers to make faster adjustments to therapy plans, resulting in improved disease management and patient outcomes. In addition, the rising adoption of advanced diabetes care solutions is improving the overall quality of life for individuals living with diabetes by minimizing the risk of severe health complications. Consequently, the expanding use of these devices continues to strengthen the growth of the diabetes care drugs devices market by enhancing patient care, improving clinical efficiency, and supporting long-term disease management.

The market is growing due to the increasing prevalence of diabetes resulting from aging, obesity, and unhealthy lifestyle choices. Obesity is a significant factor leading to diabetes. According to the latest data published by the World Health Organization in 2025, more than 2.5 billion adults aged 18 years and older were overweight in 2022, including over 890 million adults living with obesity. In addition, the worldwide prevalence of obesity has more than doubled since 1990, with approximately 16% of the global adult population classified as obese. Furthermore, the World Obesity Federation reported in its 2025 World Obesity Atlas that the number of adults living with obesity is projected to increase nearly 1.53 billion by 2035. Rising obesity levels are significantly increasing the risk of Type 2 diabetes, cardiovascular diseases, and metabolic disorders, thereby driving the demand for continuous glucose monitoring systems, insulin delivery devices, and other advanced diabetes management technologies during the forecast period.

The presence of a substantial elderly population, affordable healthcare options, cost-effective labor, and less rigorous regulatory frameworks are driving diabetic device manufacturers to expand. They are prioritizing exploiting opportunities in emerging markets to increase their market dominance. The demand for diabetes devices is also rising due to technological advancements, including introducing of advanced insulin pumps and pens. Significant companies are concentrating on technological advancements and creating advanced products to secure a significant portion of the market. For instance, in April 2025, Medtronic announced the U.S. FDA submission for its interoperable MiniMed 780G insulin pump designed for integration with Abbott's advanced CGM platform. The development is expected to accelerate the adoption of connected diabetes management ecosystems by improving interoperability, enhancing glucose control automation, and expanding access to advanced insulin delivery technologies across global markets.

Global Diabetes Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, Grand View Research has segmented the global diabetes devices market report based on type, distribution channel, end-use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • BGM Devices
    • Self-Monitoring Devices
    • Blood Glucose Meters
    • Testing Strips
    • Lancets
    • Continuous Glucose Monitoring Devices
    • Sensors
    • Transmitters
    • Receiver
  • Insulin Delivery Devices
    • Pens
    • Pum
    • Syringes
    • Jet Injectors
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital pharmacies
  • Retail Pharmacies
  • Diabetes Clinics/Centers
  • Online Pharmacies
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Centers
  • Homecare
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Thailand
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Distribution Channel
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Distribution Channel outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Diabetes Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Diabetes Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Diabetes Devices Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Diabetes Devices Market: Type Movement Analysis
  • 4.3. Diabetes Devices Market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. BGM Devices
    • 4.5.1. BGM Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Self Monitoring Devices
      • 4.5.2.1. Self Monitoring Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.2. Blood Glucose Meter
        • 4.5.2.2.1. Blood Glucose Meter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.3. Testing Strips
        • 4.5.2.3.1. Testing Strips Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.4. Lancets
        • 4.5.2.4.1. Lancets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Continuous Glucose Monitoring Devices
      • 4.5.3.1. Continous Glucose Monitoring Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.2. Sensors
        • 4.5.3.2.1. Sensors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.3. Transmitter
        • 4.5.3.3.1. Transmitters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.4. Receiver
        • 4.5.3.4.1. Receivers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Insulin Delivery Devices
    • 4.6.1. Insulin Delivery Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Pens
      • 4.6.2.1. Pens Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Pumps
      • 4.6.3.1. Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Syringes
      • 4.6.4.1. Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.5. Jet Injector
      • 4.6.5.1. Jet Injector Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Diabetes Devices Market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Diabetes Devices Market: Distribution Channel Movement Analysis
  • 5.3. Diabetes Devices Market by Distribution Channel Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Hospital Pharmacies
    • 5.5.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Retail Pharmacies
    • 5.6.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Diabetes Clinics/ Centers
    • 5.7.1. Diabetes Clinics/ Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Online Pharmacies
    • 5.8.1. Online PharmaciesMarket Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Diabetes Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Diabetes Devices Market: End Use Movement Analysis
  • 6.3. Diabetes Devices Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Dignostic Centers
    • 6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Homecare
    • 6.7.1. Homecare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Diabetes Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Diabetes Devices Market Movement Analysis
  • 7.3. Diabetes Devices Market: Regional Estimates & Trend Analysis by Type & Distribution Channel
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. North America
    • 7.5.1. North America Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Europe
    • 7.5.5. Europe Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. UK
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement scenario
      • 7.5.6.5. UK Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Germany
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. Germany Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. France
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. France Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Italy
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. Italy Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.10. Spain
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Spain Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.11. Denmark
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Denmark Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.12. Sweden
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Sweden Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.13. Norway
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Norway Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Mexico
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Mexico Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. Argentina
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. Argentina Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Medtronic plc
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Abbott Laboratories
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. F.Hoffmann-La-Ltd.
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Bayer AG
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Lifescan, Inc.
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. B Braun Melsungen AG
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Lifescan, Inc.
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Dexcom Inc.
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Insulet Corporation
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Ypsomed Holdings
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. Companion Medical
      • 8.2.11.1. Company Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Product Benchmarking
      • 8.2.11.4. Strategic Initiatives
    • 8.2.12. Sanofi
      • 8.2.12.1. Company Overview
      • 8.2.12.2. Financial Performance
      • 8.2.12.3. Product Benchmarking
      • 8.2.12.4. Strategic Initiatives
    • 8.2.13. Valeritas Holding Inc.
      • 8.2.13.1. Company Overview
      • 8.2.13.2. Financial Performance
      • 8.2.13.3. Product Benchmarking
      • 8.2.13.4. Strategic Initiatives
    • 8.2.14. Novo Nordisk
      • 8.2.14.1. Company Overview
      • 8.2.14.2. Financial Performance
      • 8.2.14.3. Product Benchmarking
      • 8.2.14.4. Strategic Initiatives
    • 8.2.15. Arkray, Inc.
      • 8.2.15.1. Company Overview
      • 8.2.15.2. Financial Performance
      • 8.2.15.3. Product Benchmarking
      • 8.2.15.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 4. Global diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 5. Global Diabetes Devices market, by end use, 2021 - 2033 (USD Million)
  • Table 6. North America diabetes devices market, by country, 2021 - 2033 (USD Million)
  • Table 7. North America diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 8. North America diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 9. North America diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 10. U.S. diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 11. U.S. diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 12. U.S. diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 13. Canada diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 14. Canada diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 15. Canada diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 16. Europe diabetes devices market, by country, 2021 - 2033 (USD Million)
  • Table 17. Europe diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 18. Europe diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 19. Europe diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 20. UK diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 21. UK diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 22. UK diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 23. Germany diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 24. Germany diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 25. Germany diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 26. France diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 27. France diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 28. France diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 29. Italy diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 30. Italy diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 31. Italy diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 32. Denmark diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 33. Denmark diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 34. Denmark diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 35. Sweden diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 36. Sweden diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 37. Sweden diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 38. Norway diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 39. Norway diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 40. Norway diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 41. Asia Pacific diabetes devices market, by country, 2021 - 2033 (USD Million)
  • Table 42. Asia Pacific diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 43. Asia Pacific diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 44. Asia Pacific diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 45. Japan diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 46. Japan diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 47. Japan diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 48. China diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 49. China diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 50. China diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 51. India diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 52. India diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 53. India diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 54. Australia diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 55. Australia diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 56. Australia diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 57. South Korea diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 58. South Korea diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 59. South Korea diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 60. Thailand diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 61. Thailand diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 62. Thailand diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 63. Latin America diabetes devices market, by Country, 2021 - 2033 (USD Million)
  • Table 64. Latin America diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 65. Latin America diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 66. Latin America diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 67. Brazil diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 68. Brazil diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 69. Brazil diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 70. Mexico diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 71. Mexico diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 72. Mexico diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 73. Argentina diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 74. Argentina diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 75. Argentina diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 76. Middle East & Africa diabetes devices market, by country, 2021 - 2033 (USD Million)
  • Table 77. Middle East & Africa diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 78. Middle East & Africa diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 79. Middle East & Africa diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 80. South Africa diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 81. South Africa diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 82. South Africa diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 83. Saudi Arabia diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 84. Saudi Arabia diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 85. Saudi Arabia diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 86. UAE diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 87. UAE diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 88. UAE diabetes devices market, by end use, 2021 - 2033 (USD Million)
  • Table 89. Kuwait diabetes devices market, by type, 2021 - 2033 (USD Million)
  • Table 90. Kuwait diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 91. Kuwait diabetes devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Diabetes devices market: Market outlook
  • Fig. 14 Diabetes devices market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Diabetes devices market driver impact
  • Fig. 20 Diabetes devices market restraint impact
  • Fig. 21 Diabetes devices market: type movement analysis
  • Fig. 22 Diabetes devices market: type outlook and key takeaways
  • Fig. 23 Blood glucose monitoring devices market estimates and forecast, 2021 - 2033
  • Fig. 24 Self-monitoring devices market estimates and forecast, 2021 - 2033
  • Fig. 25 Blood glucose meters market estimates and forecast, 2021 - 2033
  • Fig. 26 Testing strips market estimates and forecast, 2021 - 2033
  • Fig. 27 Lancets market estimates and forecast, 2021 - 2033
  • Fig. 28 Continuous glucose monitoring devices market estimates and forecast, 2021 - 2033
  • Fig. 29 Sensors market estimates and forecast, 2021 - 2033
  • Fig. 30 Transmitters market estimates and forecast, 2021 - 2033
  • Fig. 31 Receivers market estimates and forecast, 2021 - 2033
  • Fig. 32 Insulin delivery devices market estimates and forecast, 2021 - 2033
  • Fig. 33 Pumps market estimates and forecast, 2021 - 2033
  • Fig. 34 Pens market estimates and forecast, 2021 - 2033
  • Fig. 35 Syringes market estimates and forecast, 2021 - 2033
  • Fig. 36 Jet injectors market estimates and forecast, 2021 - 2033
  • Fig. 37 Diabetes devices market: distribution channel movement analysis
  • Fig. 38 Diabetes devices market: distribution channel outlook and key takeaways
  • Fig. 39 Hospital pharmacies market estimates and forecast, 2021 - 2033
  • Fig. 40 Retail pharmacies market estimates and forecast, 2021 - 2033
  • Fig. 41 Diabetes clinics/centers market estimates and forecast, 2021 - 2033
  • Fig. 42 Online pharmacies market estimates and forecast, 2021 - 2033
  • Fig. 43 Others market estimates and forecast, 2021 - 2033
  • Fig. 44 Diabetes devices market: end use movement analysis
  • Fig. 45 Diabetes devices market: end use outlook and key takeaways
  • Fig. 46 Hospitals market estimates and forecast, 2021 - 2033
  • Fig. 47 Diagnostic centers market estimates and forecast, 2021 - 2033
  • Fig. 48 Homecare market estimates and forecast, 2021 - 2033
  • Fig. 49 Global Diabetes devices market: regional movement analysis
  • Fig. 50 Global Diabetes devices market: regional outlook and key takeaways
  • Fig. 51 North America
  • Fig. 52 North America market estimates and forecast, 2021 - 2033
  • Fig. 53 US
  • Fig. 54 US market estimates and forecast, 2021 - 2033
  • Fig. 55 Canada
  • Fig. 56 Canada market estimates and forecast, 2021 - 2033
  • Fig. 57 Europe
  • Fig. 58 Europe market estimates and forecast, 2021 - 2033
  • Fig. 59 UK
  • Fig. 60 UK market estimates and forecast, 2021 - 2033
  • Fig. 61 Germany
  • Fig. 62 Germany market estimates and forecast, 2021 - 2033
  • Fig. 63 France
  • Fig. 64 France market estimates and forecast, 2021 - 2033
  • Fig. 65 Italy
  • Fig. 66 Italy market estimates and forecast, 2021 - 2033
  • Fig. 67 Spain
  • Fig. 68 Spain market estimates and forecast, 2021 - 2033
  • Fig. 69 Denmark
  • Fig. 70 Denmark market estimates and forecast, 2021 - 2033
  • Fig. 71 Sweden
  • Fig. 72 Sweden market estimates and forecast, 2021 - 2033
  • Fig. 73 Norway
  • Fig. 74 Norway market estimates and forecast, 2021 - 2033
  • Fig. 75 Asia Pacific
  • Fig. 76 Asia Pacific market estimates and forecast, 2021 - 2033
  • Fig. 77 Japan
  • Fig. 78 Japan market estimates and forecast, 2021 - 2033
  • Fig. 79 China
  • Fig. 80 China market estimates and forecast, 2021 - 2033
  • Fig. 81 India
  • Fig. 82 India market estimates and forecast, 2021 - 2033
  • Fig. 83 South Korea
  • Fig. 84 South Korea market estimates and forecast, 2021 - 2033
  • Fig. 85 Thailand
  • Fig. 86 Thailand market estimates and forecast, 2021 - 2033
  • Fig. 87 Australia
  • Fig. 88 Australia market estimates and forecast, 2021 - 2033
  • Fig. 89 Latin America
  • Fig. 90 Latin America market estimates and forecast, 2021 - 2033
  • Fig. 91 Brazil
  • Fig. 92 Brazil market estimates and forecast, 2021 - 2033
  • Fig. 93 Mexico
  • Fig. 94 Mexico market estimates and forecast, 2021 - 2033
  • Fig. 95 Argentina
  • Fig. 96 Argentina market estimates and forecast, 2021 - 2033
  • Fig. 97 Middle East and Africa
  • Fig. 98 Middle East and Africa market estimates and forecast, 2021 - 2033
  • Fig. 99 Saudi Arabia
  • Fig. 100 Saudi Arabia market estimates and forecast, 2021 - 2033
  • Fig. 101 South Africa
  • Fig. 102 South Africa market estimates and forecast, 2021 - 2033
  • Fig. 103 UAE
  • Fig. 104 UAE market estimates and forecast, 2021 - 2033
  • Fig. 105 Kuwait
  • Fig. 106 Kuwait market estimates and forecast, 2021 - 2033
  • Fig. 107 Participant categorization - Diabetes devices market
  • Fig. 108 Market share of key market players - Diabetes devices market